It isn't just me: up to 10% of American adults have diabetes. Most either don't know, or don't do anything about it.

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...

At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...

Fewer Cognitive Side Effects: With the potential to avoid sedation and cognitive impairment, Ketamir-2 offers an improved ...

Charcot Foot, a rare diabetes-related complication, involves severe foot deformities due to nerve damage. Symptoms include ...

Diabetic peripheral neuropathy, which affects about 30% of diabetics, can cause numbness, tingling, or burning in the feet.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...

Erectile dysfunction (ED) affects up to 66% of diabetic men globally, with risk factors like age, long-term diabetes, and ...

Adolescents with type 2 diabetes have a higher incidence of complications than adults with type 2 diabetes or adolescents with type 1 diabetes.

Lexicon's Inpefa faces fierce competition from established SGLT2 inhibitors, like Farxiga and Jardiance. Read why LXRX stock ...